<?xml version="1.0" encoding="UTF-8"?>
<p>Of note, binding of the S1 COVID-19 protein to ACE2 has an effect on the reninâ€“angiotensin system (RAS), leading to possible exacerbation of severe pneumonia. Currently, ACE1 and angiotensin type-1 receptor (AT1R) inhibitors are believed to reduce pulmonary inflammation, thus reducing the mortality rate [
 <xref rid="B16-ijms-21-05145" ref-type="bibr">16</xref>,
 <xref rid="B54-ijms-21-05145" ref-type="bibr">54</xref>].
</p>
